← Back
Data updated: Mar 10, 2026
ROCKWELL MEDCL
Metabolic
ROCKWELL MEDCL is a generic drug manufacturer focused on Metabolic.
2003
Since
1
Drugs
-
Trials
0
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
No recent activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Metabolic 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2003-09-17
- Latest
- 2014-06-17
- Applications
- 1